Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Enviri
NVRI
$606M
| $9.62M | 0.01% |
477,214
+94,800
| +25% | +$2.04M |
|
|
BDSI
1277
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $9.61M | 0.01% |
1,813,595
+832,173
| +85% | +$3.8M |
|
1278
Kratos Defense & Security Solutions
KTOS
$9.89B
| $9.6M | 0.01% |
614,368
+573,902
| +1,418% | +$9.03M |
|
1279
CALL
Medtronic
MDT
$117B
| $9.6M | 0.01% |
+105,400
| New | +$9.43M |
|
1280
PUT
Thermo Fisher Scientific
TMO
$233B
| $9.58M | 0.01% |
35,000
+25,000
| +250% | +$6.22M |
|
1281
Addus HomeCare
ADUS
$2.26B
| $9.58M | 0.01% |
150,627
+129,811
| +624% | +$8.34M |
|
1282
PUT
Skyworks Solutions
SWKS
$9.69B
| $9.55M | 0.01% |
115,800
+103,700
| +857% | +$8.01M |
|
1283
National Bank Holdings
NBHC
$1.86B
| $9.54M | 0.01% |
286,980
-183,300
| -39% | -$6.14M |
|
|
CZZ
1284
DELISTED
Cosan Limited
CZZ
| $9.52M | 0.01% |
821,043
+460,316
| +128% | +$5.07M |
|
|
SASR
1285
DELISTED
Sandy Spring Bancorp Inc
SASR
| $9.51M | 0.01% |
304,154
+95,776
| +46% | +$3.17M |
|
|
MNDT
1286
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $9.49M | 0.01% |
565,537
-1,602,706
| -74% | -$27M |
|
|
TLRD
1287
DELISTED
Tailored Brands, Inc.
TLRD
| $9.48M | 0.01% |
1,209,088
+893,726
| +283% | +$10.6M |
|
|
WNS
1288
DELISTED
WNS Holdings
WNS
| $9.48M | 0.01% |
177,918
+158,315
| +808% | +$7.94M |
|
|
RSX
1289
PUT
DELISTED
VanEck Russia ETF
RSX
| $9.48M | 0.01% |
460,000
-292,500
| -39% | -$6.02M |
|
1290
American Airlines Group
AAL
$9.12B
| $9.47M | 0.01% |
298,281
-1,640,589
| -85% | -$55.1M |
|
|
FIT
1291
CALL
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $9.47M | 0.01% |
1,600,000
-300,000
| -16% | -$1.82M |
|
1292
NewMarket
NEU
$8.49B
| $9.46M | 0.01% |
21,815
+19,665
| +915% | +$8.31M |
|
1293
Grupo Aeroportuario Centro Norte
OMAB
$4.95B
| $9.42M | 0.01% |
208,879
+118,238
| +130% | +$5.26M |
|
1294
Boston Beer
SAM
$1.93B
| $9.4M | 0.01% |
31,908
+20,773
| +187% | +$5.68M |
|
|
GWR
1295
DELISTED
Genesee & Wyoming Inc.
GWR
| $9.4M | 0.01% |
107,920
+96,131
| +815% | +$7.8M |
|
|
FSCT
1296
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $9.38M | 0.01% |
223,825
+9,191
| +4% | +$330K |
|
1297
Dycom Industries
DY
$11.3B
| $9.38M | 0.01% |
204,078
+10,777
| +6% | +$590K |
|
1298
Deluxe
DLX
$1.1B
| $9.37M | 0.01% |
214,382
-31,140
| -13% | -$1.4M |
|
1299
AES
AES
$10.5B
| $9.37M | 0.01% |
518,243
-265,844
| -34% | -$4.47M |
|
1300
AB InBev
BUD
$155B
| $9.35M | 0.01% |
+111,353
| New | +$8.56M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.